887 related articles for article (PubMed ID: 12702898)
21. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
[TBL] [Abstract][Full Text] [Related]
22. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
23. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
25. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
26. Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report.
Mobascher J; Zielasek J; Schuier FJ; Mobascher A; Grohmann R; Agelink MW; Cordes J
Pharmacopsychiatry; 2005 Nov; 38(6):329-30. PubMed ID: 16342008
[TBL] [Abstract][Full Text] [Related]
27. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
28. Association between clozapine-induced agranulocytosis and HLA subtyping.
Lopez-Garcia P; Teresa Rodriguez J; De Castro P; Landecho I; Zapata R
J Clin Psychiatry; 2006 Oct; 67(10):1652-3. PubMed ID: 17107265
[No Abstract] [Full Text] [Related]
29. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
Herceg M; Muzinić L; Jukić V
Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
[TBL] [Abstract][Full Text] [Related]
30. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
31. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
[TBL] [Abstract][Full Text] [Related]
32. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
33. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels.
Pollmächer T; Fenzel T; Mullington J; Hinze-Selch D
Pharmacopsychiatry; 1997 Jul; 30(4):118-21. PubMed ID: 9271776
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].
van Gool AR; van der Velden MT; Oosten AW; van Meerten E; Verhoeven WM; Loonen AJ
Tijdschr Psychiatr; 2008; 50(10):673-8. PubMed ID: 18951346
[TBL] [Abstract][Full Text] [Related]
35. Optimizing treatment with clozapine.
Conley RR
J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
[TBL] [Abstract][Full Text] [Related]
36. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
Comacchio C; Dusi N; Lasalvia A
J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
[No Abstract] [Full Text] [Related]
37. G-CSF and the management of clozapine-induced agranulocytosis.
Gerson SL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis.
Nielsen H
J Intern Med; 1993 Nov; 234(5):529-31. PubMed ID: 7693847
[TBL] [Abstract][Full Text] [Related]
39. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
Raveendranathan D; Sharma E; Venkatasubramanian G; Rao MG; Varambally S; Gangadhar BN
Gen Hosp Psychiatry; 2013; 35(5):574.e5-6. PubMed ID: 22902258
[TBL] [Abstract][Full Text] [Related]
40. [Agranulocytosis in a child with schizophrenia treated with clozapine--clinical findings and therapy, a case report].
Reitzle K; Warnke A; Wewetzer C; Müller H
Z Kinder Jugendpsychiatr Psychother; 2001 May; 29(2):137-43. PubMed ID: 11393052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
